NDC 85509-2750-06 - Diclofenac Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85509-2750
- Requested NDC
- 85509-2750-06
- Package NDCs from labels
- 85509-2750-3, 85509-2750-6, 85509-2750-9, 85509-2750-1, 85509-2750-06
- Manufacturer
- Phoenix RX LLC
- Effective date
- 2025-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Potassium - Phoenix RX LLC | Phoenix RX LLC | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85509-2750-1 | Diclofenac Potassium | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 3 | |
| 85509-2750-3 | Diclofenac Potassium | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 3 | |
| 85509-2750-6 | Diclofenac Potassium | 60 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 60 | 3 | |
| 85509-2750-9 | Diclofenac Potassium | 90 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 90 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85509-2750-1 | EA - Each | 85509-2750 | d7d02572-2387-41b0-b5ab-193245590f1b | 1 | 2025-12-16 |
| 85509-2750-3 | EA - Each | 85509-2750 | 00c86f96-f41e-4fd2-b6f7-15aff76984c8 | 1 | 2025-12-16 |
| 85509-2750-6 | EA - Each | 85509-2750 | dbd87f77-981e-435b-8aee-17ac22154190 | 1 | 2025-12-16 |
| 85509-2750-9 | EA - Each | 85509-2750 | b475cd92-4907-43e9-a509-046fa1cd97b7 | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 48N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4372c4-b87a-91ab-e063-6294a90a6807 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 49C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA BLACK CUSHION FOUNDATION 13N1 | OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE | Amorepacific Corporation | 5aff3d25-d034-0815-e063-6294a90a8664 | 2026-10-29 | Warnings | 15FIX9V2JP |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM | Umedica Laboratories USA Inc. | 33930285-dd97-415c-9e2a-491bd7b12af9 | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Blue Lizard Sensitive SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 32d78048-d281-1d80-e063-6394a90aec19 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 32W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eed2165-afc2-6958-e063-6294a90add58 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 34O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eedd87b-a7b1-1abc-e063-6294a90ae29e | 2026-10-28 | Warnings | 15FIX9V2JP |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM | Nivagen Pharmaceuticals, Inc. | eb52a015-23cd-40f6-bf83-6749fc34947c | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM TABLETS | NIVAGEN PHARMACEUTICALS, INC. | 1f06a404-07c3-4414-8c5c-357c01d6ccb3 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| HERA SILKYSTAY FOUNDATION 26N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7151e-4f83-4aca-e063-6294a90a9818 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 26W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7276d-fcaf-65b2-e063-6394a90ac220 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec73566-5d67-7153-e063-6394a90aba33 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec75100-153c-80cd-e063-6294a90a6d51 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec77f7a-4621-ac0c-e063-6294a90a3f70 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7ab15-9cc1-d53a-e063-6294a90a4111 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec83b87-08bc-7590-e063-6294a90a0b78 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec857a3-7fd1-6461-e063-6394a90aacd7 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec871dc-f74e-765c-e063-6394a90a27a5 | 2026-10-26 | Warnings | 15FIX9V2JP |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Ascend Laboratories, LLC | f675a627-c944-4ec6-8c08-b5fdb78dc269 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.